FREE SHIPPING ON ORDERS OVER $150

glp 1 drugs and crohn's disease GLP-1 for Disease: Current Evidence Treatment Options Primer: The Skinny on GLP-1s

$21.59

Quantity
- +
Description

A human cellular model for studying the regulation of glucagon-like peptide-1 secretion

glp 1 drugs and crohn's disease GLP-1 for Disease: Current Evidence Treatment Options Primer: The Skinny on GLP-1s

Same general shape

glp 1 drugs and crohn's disease GLP-1 for Disease: Current Evidence Treatment Options Primer: The Skinny on GLP-1s

Truncated glucagon-like peptide-1 (proglucagon 78-107 amide), an intestinal insulin-releasing peptide, has specific receptors on rat insulinoma cells (RIN 5AH) FEBS Letters

glp 1 drugs and crohn's disease GLP-1 for Disease: Current Evidence Treatment Options Primer: The Skinny on GLP-1s

Victoza is approved to treat type 2 diabetes, not obesity

glp 1 drugs and crohn's disease GLP-1 for Disease: Current Evidence Treatment Options Primer: The Skinny on GLP-1s

Placebo was provided as normal saline, the volume matching the investigational drug at each dose level

glp 1 drugs and crohn's disease GLP-1 for Disease: Current Evidence Treatment Options Primer: The Skinny on GLP-1s

Article Google Scholar French, S

glp 1 drugs and crohn's disease GLP-1 for Disease: Current Evidence Treatment Options Primer: The Skinny on GLP-1s

You may also like

recommand products